List of Studies ( Metabolite:Chlorpropamide)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004032 | AN006668 | SIRT3 induces cell senescence via regulating deacetylation of SLC25A13 in colorectal cancer | Colorectal Tissue | Human | Cancer | Sichuan University | LC-MS |
| ST004032 | AN006669 | SIRT3 induces cell senescence via regulating deacetylation of SLC25A13 in colorectal cancer | Colorectal Tissue | Human | Cancer | Sichuan University | LC-MS |
| ST003768 | AN006186 | The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass | Leaf | Grass | Hunan Agricultural University | LC-MS | |
| ST003768 | AN006186 | The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass | Roots | Grass | Hunan Agricultural University | LC-MS | |
| ST003736 | AN006130 | The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass (Rumex patientia L.× Rumex tianschanicus A. LOS) | Rhizosphere | Rumex patientia | Hunan Agricultural University | LC-MS | |
| ST003642 | AN005981 | Hexosamine Biosynthesis Disruption Impairs GPI Production and Arrests Plasmodium falciparum Growth at Schizont Stages | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST003533 | AN005804 | Nutrient intervention protects against retinal dysfunction from disrupted peroxisomal fatty acid oxidation | Eye tissue | Mouse | Eye disease | Boston Children's Hospital | LC-MS |
| ST003224 | AN005286 | The Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD0156 is a Potent Inhibitor of Plasmodium Phosphatidylinositol 4-Kinase and is an Attractive Candidate for Repositioning Against Malaria | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003387 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003388 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003389 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003390 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002024 | AN003294 | Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003277 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003278 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003279 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002007 | AN003270 | Isotope tracing analysis of stress erythroid progenitors | Cultured cells | Mouse | Inflammation | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Blood | Human | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Cultured cells | Human | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001660 | AN002711 | Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001299 | AN002163 | Metatranscriptomic Analysis of the Mouse Gut Microbiome Response to the Persistent Organic Pollutant 2,3,7,8-Tetrachlorodibenzofuran | Cecum | Mouse | Pennsylvania State University | LC-MS | |
| ST001232 | AN002050 | Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST000046 | AN000078 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |